🇺🇸 FDA
Pipeline program

Dapagliflozin+Standard Treatment for 12 weeks,washout period for 4 weeks,then Standard Treatment alone for12 weeks

DAPA-PedHKD

Phase 3 small_molecule active

Quick answer

Dapagliflozin+Standard Treatment for 12 weeks,washout period for 4 weeks,then Standard Treatment alone for12 weeks for Pediatric Hereditary Kidney Diseases is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Pediatric Hereditary Kidney Diseases
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials